Answers are grounded in this paper and cite their sources.
To assess the relationship between subclinical hypothyroidism (SCH), thyroid autoimmunity (TAI), and ovarian reserve parameters in women newly diagnosed with polyendocrine metabolic ovarian syndrome (PMOS), and to evaluate whether TAI modifies this relationship. This retrospective cross-sectional study included irregularly menstruating women with PMOS and no overt thyroid dysfunction. Participants were stratified by thyroid-stimulating hormone (TSH) concentrations as SCH0 (0.27–2.49 mIU/L), SCH1 (2.50–4.20 mIU/L), and SCH2 (> 4.20 mIU/L), and by TAI status. Group comparisons, correlation analyses, and multivariable linear and logistic regression models were performed. Among 897 women with PMOS, no significant differences in Anti-Müllerian hormone (AMH) ( p = 0.362), follicle-stimulating hormone ( p = 0.566), luteinizing hormone ( p = 0.528), estradiol ( p = 0.833), polycystic ovarian morphology ( p = 0.793), or cycle-related ovarian structures ( p = 0.066) were found across TSH categories. In phenotype D, AMH varied by TSH category ( p = 0.017). After multivariable adjustment, thyroid-related variables showed no independent associations with ovarian reserve markers or related parameters (all p > 0.05). In women newly diagnosed with PMOS, thyroid-related variables were not independently associated with ovarian reserve markers, with variability primarily explained by body mass index, age, and PMOS phenotype.
No takes yet. Share an insight, caveat, or question.
Baran et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: